Evidence map›Paper›PMID 38750597›Full record

ArticleJournal of nanobiotechnology2024

An injectable refrigerated hydrogel for inducing local hypothermia and neuroprotection against traumatic brain injury in mice.

Yuhan Han, Zhengzhong Han, Xuyang Huang, Shanshan Li, Guoliang Jin, Junfeng Feng, Decheng Wu, Hongmei Liu

Abstract read
In one paragraph

Article in Journal of nanobiotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. MgSOTheranostics · 2025
    Article
  3. Review
  4. Review
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuhan Han *Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
Zhengzhong Han *Department of Neurosurgery, Xuzhou Children's Hospital, Xuzhou, 221000, Jiangsu, China.
Xuyang Huang *Institute of Nervous System Diseases, Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.
Shanshan LiDepartment of Forensic Medicine, Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.
Guoliang JinDepartment of Neurology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.
Junfeng FengBrain Injury Center, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Institute of Head Trauma, Shanghai, 200127, China. fengjfmail@163.com.
Decheng WuDepartment of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China. wudc@sustech.edu.cn.
Hongmei LiuDepartment of Biomedical Engineering, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China. liuhm@sustech.edu.cn.

Funding

Basic Research Program of Xuzhou Department of Science and Technology No. KC21050Guangdong Provincial Key Laboratory of Advanced Biomaterials 2022B1212010003Jiaxing Public Welfare Project 2023AY31008Medical Research Project of Jiangsu Commission of Health No. H2023032Shenzhen Science and Technology Innovation Commission KQTD20200820113012029Shenzhen Science and Technology Program KJZD20230923114612025
6 · The paper itself

Abstract

backgroundHypothermia is a promising therapy for traumatic brain injury (TBI) in the clinic. However, the neuroprotective outcomes of hypothermia-treated TBI patients in clinical studies are inconsistent due to several severe side effects. Here, an injectable refrigerated hydrogel was designed to deliver 3-iodothyronamine (T1AM) to achieve a longer period of local hypothermia for TBI treatment. Hydrogel has four advantages: (1) It can be injected into injured sites after TBI, where it forms a hydrogel and avoids the side effects of whole-body cooling. (2) Hydrogels can biodegrade and be used for controlled drug release. (3) Released T1AM can induce hypothermia. (4) This hydrogel has increased medical value given its simple operation and ability to achieve timely treatment.

methodsPol/T hydrogels were prepared by a low-temperature mixing method and characterized. The effect of the Pol/T hydrogel on traumatic brain injury in mice was studied. The degradation of the hydrogel at the body level was observed with a small animal imager. Brain temperature and body temperature were measured by brain thermometer and body thermometer, respectively. The apoptosis of peripheral nerve cells was detected by immunohistochemical staining. The protective effect of the hydrogels on the blood-brain barrier (BBB) after TBI was evaluated by the Evans blue penetration test. The protective effect of hydrogel on brain edema after injury in mice was detected by Magnetic resonance (MR) in small animals. The enzyme linked immunosorbent assay (ELISA) method was used to measure the levels of inflammatory factors. The effects of behavioral tests on the learning ability and exercise ability of mice after injury were evaluated.

resultsThis hydrogel was able to cool the brain to hypothermia for 12 h while maintaining body temperature within the normal range after TBI in mice. More importantly, hypothermia induced by this hydrogel leads to the maintenance of BBB integrity, the prevention of cell death, the reduction of the inflammatory response and brain edema, and the promotion of functional recovery after TBI in mice. This cooling method could be developed as a new approach for hypothermia treatment in TBI patients.

conclusionOur study showed that injectable and biodegradable frozen Pol/T hydrogels to induce local hypothermia in TBI mice can be used for the treatment of traumatic brain injury.

Indexed as

Blood-Brain BarrierBrain Injuries, TraumaticHydrogelsHypothermia, InducedAnimalsBody TemperatureBrainDisease Models, AnimalMaleMiceMice, Inbred C57BLNeuroprotectionNeuroprotective AgentsHydrogelsNeuroprotective AgentsHydrogelLocal hypothermiaNeuroprotectionTraumatic brain injury

Identifiers

PMID38750597
PMCPMC11095020

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.